JP2005511088A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511088A5 JP2005511088A5 JP2003551302A JP2003551302A JP2005511088A5 JP 2005511088 A5 JP2005511088 A5 JP 2005511088A5 JP 2003551302 A JP2003551302 A JP 2003551302A JP 2003551302 A JP2003551302 A JP 2003551302A JP 2005511088 A5 JP2005511088 A5 JP 2005511088A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- gzip
- composition
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 239000005557 antagonist Substances 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 101150112998 ADIPOQ gene Proteins 0.000 claims 3
- 101150096655 APM1 gene Proteins 0.000 claims 3
- 101100162826 Dictyostelium discoideum apm2 gene Proteins 0.000 claims 3
- 101100053794 Homo sapiens ZBTB7C gene Proteins 0.000 claims 3
- 102100023250 Zinc finger and BTB domain-containing protein 7C Human genes 0.000 claims 3
- 230000037396 body weight Effects 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- 230000002608 insulinlike Effects 0.000 claims 1
- 230000037356 lipid metabolism Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 238000000638 solvent extraction Methods 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32772501P | 2001-10-05 | 2001-10-05 | |
| PCT/IB2002/004598 WO2003050281A2 (en) | 2001-10-05 | 2002-10-03 | Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511088A JP2005511088A (ja) | 2005-04-28 |
| JP2005511088A5 true JP2005511088A5 (enExample) | 2005-12-22 |
| JP4423038B2 JP4423038B2 (ja) | 2010-03-03 |
Family
ID=23277766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003551302A Expired - Fee Related JP4423038B2 (ja) | 2001-10-05 | 2002-10-03 | Ｇｚｉｐポリヌクレオチドおよびポリペプチドならびにその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7402393B2 (enExample) |
| EP (1) | EP1432803B1 (enExample) |
| JP (1) | JP4423038B2 (enExample) |
| AT (1) | ATE380868T1 (enExample) |
| AU (1) | AU2002339678B2 (enExample) |
| CA (1) | CA2461491A1 (enExample) |
| DE (1) | DE60224064T2 (enExample) |
| DK (1) | DK1432803T3 (enExample) |
| ES (1) | ES2295415T3 (enExample) |
| IL (2) | IL161233A0 (enExample) |
| WO (1) | WO2003050281A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE478890T1 (de) | 2002-05-31 | 2010-09-15 | Serono Genetics Inst Sa | Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon |
| US8252520B2 (en) * | 2002-10-11 | 2012-08-28 | Taivex Therapeutics Corporation | Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases |
| EP1548445A3 (en) * | 2003-12-22 | 2005-11-23 | F. Hoffmann-La Roche Ag | Novel targets for obesity from fat tissue |
| US20100173829A1 (en) * | 2008-11-07 | 2010-07-08 | Aston University | Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof |
| US8892184B2 (en) | 2010-10-18 | 2014-11-18 | Siemens Medical Solutions Usa, Inc. | Systems and methods for reducing interference in a dual modality imaging system |
| US9730980B2 (en) * | 2012-07-25 | 2017-08-15 | University Of Cincinnati | Method of treating type I diabetes using apolipoprotein A-IV |
| US11213567B2 (en) * | 2017-09-29 | 2022-01-04 | L&C Bio Co., Ltd. | ZAG-derived peptide and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9811465D0 (en) * | 1998-05-29 | 1998-07-29 | Tisdale Michael J | Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| WO2001051645A1 (en) * | 2000-01-14 | 2001-07-19 | Genset | Obg3 globular head and uses thereof for decreasing body mass |
| WO2003033534A2 (en) * | 2001-10-12 | 2003-04-24 | Genset S.A. | Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
-
2002
- 2002-10-03 WO PCT/IB2002/004598 patent/WO2003050281A2/en not_active Ceased
- 2002-10-03 EP EP02777726A patent/EP1432803B1/en not_active Expired - Lifetime
- 2002-10-03 AU AU2002339678A patent/AU2002339678B2/en not_active Ceased
- 2002-10-03 CA CA002461491A patent/CA2461491A1/en not_active Abandoned
- 2002-10-03 JP JP2003551302A patent/JP4423038B2/ja not_active Expired - Fee Related
- 2002-10-03 ES ES02777726T patent/ES2295415T3/es not_active Expired - Lifetime
- 2002-10-03 DE DE60224064T patent/DE60224064T2/de not_active Expired - Lifetime
- 2002-10-03 DK DK02777726T patent/DK1432803T3/da active
- 2002-10-03 AT AT02777726T patent/ATE380868T1/de active
- 2002-10-03 IL IL16123302A patent/IL161233A0/xx unknown
- 2002-10-03 US US10/491,772 patent/US7402393B2/en not_active Expired - Fee Related
-
2004
- 2004-04-01 IL IL161233A patent/IL161233A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| D'souza et al. | B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening | |
| Castaman et al. | Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A | |
| JP2000312590A5 (enExample) | ||
| EP2270041A3 (en) | KDR peptides and vaccines comprising the same | |
| RU2017143580A (ru) | Улучшенные последовательности уриказы и способы лечения | |
| JP2001511347A5 (enExample) | ||
| JP2005511088A5 (enExample) | ||
| AU2003242352A8 (en) | Adiponectin receptor and gene coding for the same | |
| AU2003240631A8 (en) | A t cell subpopulation regulating gut immunity | |
| CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
| JP2008517900A5 (enExample) | ||
| IL174903A0 (en) | IN VITRO METHOD FOR THE DIAGNOSIS OF CARDIOVASCULAR FUNCTIONALITY OF BONE MARROW-PRECURSOR CELLS (BMPs) AND/OR BLOOD DERIVED CIRCULATING PRECURSOR CELLS (BDPS) | |
| JP2005512558A5 (enExample) | ||
| AU2006220501A1 (en) | Human leptin-derived polypeptides and uses thereof | |
| JP2008509084A5 (enExample) | ||
| Chadwick et al. | Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes | |
| Milliken et al. | Effects of synthetic peptide fragments of teleocalcin (hypocalcin) on calcium uptake in juvenile rainbow trout (Salmo gairdneri) | |
| JP2008502592A5 (enExample) | ||
| WO2002008383A3 (en) | Sp110, a polypeptide component of the nuclear body | |
| JP2004513631A5 (enExample) | ||
| JP2004101509A5 (enExample) | ||
| JP2005501524A5 (enExample) | ||
| GERSL et al. | The occurrence of gastrin‐17 in the heart | |
| CA2404688A1 (en) | Nuclear factor .kappa.b inducing factor | |
| JP2001069994A5 (enExample) |